-
Uncategorized1 month agoFederal appeals court blocks mailing of abortion pill mifepristone
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone prescriptions. Friday’s...
-
Uncategorized1 month ago
Bristol Myers’ pivotal year; Should AI be swinging bigger?; and more
Bristol Myers’ pivotal year; Should AI be swinging bigger?; and more
-
Uncategorized1 month agoArvinas’ ‘Protac’ breast cancer drug cleared by FDA
Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new...
-
Uncategorized1 month ago
DNA-Containing Extracellular Vesicles Boost Antitumor Responses in Mice
A study led by investigators at Weill Cornell Medicine has found that activated T cells secrete extracellular vesicles (EVs) containing DNA, which can enter other immune...
-
Uncategorized1 month ago
Moderna in talks with FDA over Phase 4 Covid vaccine data
Moderna in talks with FDA over Phase 4 Covid vaccine data
-
Uncategorized1 month ago
FDA approves Pfizer and Arvinas’ breast cancer drug despite underwhelming data
FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data
-
Uncategorized1 month ago
Figurate SCADA System Launched to Overcome Digital Bottlenecks During Biopharma Manufacturing
Cytiva and Rockwell Automation launched the figurate supervisory control and data acquisition (SCADA) system designed to remove digital bottlenecks during biopharmaceutical manufacturing. Working across multiple instrument...
-
Uncategorized1 month ago
Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS research
Seaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. With a team largely made up of Karuna Therapeutics...
-
Uncategorized1 month agoSTAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send...
-
Uncategorized1 month agoSummit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
Summit’s decision to conduct an interim analysis of a closely watched trial backfired. Elsewhere, Axsome got a much-needed label expansion and an FDA committee sided against an...
